BioStem Technologies CEO to Present at Biotech Showcase 2025

Presentation to be webcast at 2:30 PM PT on Monday, January 13, 2025

POMPANO BEACH, Fla., Jan. 02, 2025 (GLOBE NEWSWIRE) —

BioStem Technologies, Inc.

(OTC: BSEM), a leading MedTech company focused on the development, manufacturing, and commercialization of placental-derived products for advanced wound care, announces that Jason Matuszewski, the Company’s Chief Executive Officer, will present a corporate overview and update at the Biotech Showcase 2025 conference, which is taking place in San Francisco, CA January 13-15, 2025. BioStem’s senior management will also host one-on-one meetings during the conference.

Biotech Showcase 2025 Presentation Details:

Date:

Monday, January 13, 2025


Time:

2:30 PM PT


Track:

Yosemite-C


Webcast Link:


HERE



Webcast Archive:


HERE

Request a Meeting with Management:



To schedule a one-on-one meeting at the Biotech Showcase conference or in San Francisco January 13-15, please email

adamh@pcgadvisory.com

.

About Biotech Showcase:



Biotech Showcase is an investor and networking conference devoted to providing private and public biotechnology and life sciences companies with an opportunity to present to, and meet with, investors and pharmaceutical executives in one place. Investors and biopharmaceutical executives from around the world gather at Biotech Showcase during this bellwether week which sets the tone for the coming year. Now in its 17th year, this well-established, highly respected conference features multiple tracks of presenting companies, plenary sessions, workshops, networking, and an opportunity to schedule one-to-one meetings.